Press Release - SUTUREGARD® Medical Announces How To Document Use of their Devices in Modernizing Medicine’s EHR system, EMA® | Press Release
X

SUTUREGARD® Medical, Inc. Blog

 
14Jul

Press Release - SUTUREGARD® Medical Announces How To Document Use of their Devices in Modernizing Medicine’s EHR system, EMA®

SUTUREGARD® has recently announced how to document the use of HEMIGARD® ARS and SUTUREGARD® ISR devices for your complex repairs in EMA with Modernizing Medicine.

EMA has clickable boxes to simplify your documentation and coding when using the HEMIGARD® ARS and SUTUREGARD® ISR devices for your closures. The steps are easy and identifiable, below is an example for when using the HEMIGARD®.

Step 1: After documenting the excision, click “Complex Repair”

Step 1

Step 2: EMA will ask if a SUTUREGARD® ISR or HEMIGARD® ARS device was used. Select “HEMIGARD”.

Step 2

Step 3: Select the caliber of suture used for the retention suture. You can change the default using the “sticky” green ball in the box. Typically, the HEMIGARD® is used within 2-0 nylon.

Step 3

Step 4: Select the number of HEMIGARD® strips per side of the wound. One pouch of HEMIGARD® ARS devices contains two strips, one for each side of the wound. Here, we selected 1 strip per side.

Step 4

Final Step: Mark the “complex Requirement: Retention Suture Used” box as “Yes” to confirm that you placed the HEMIGARD® ARS device(s) and retention suture(s).

Based in Portland, Oregon, SUTUREGARD® Medical, Inc is a private company offering novel medical devices for surgeons to repair challenging surgical defects more simply. SUTUREGARD® medical devices are intended to provide minimal wound trauma and reduce the healing period after surgery, providing better results for patients.

Related

Elliptical Wound Tension

Usually, excisional wounds are created with an ellipse. This allows the wound to be closed without “...

Read More >

The Next Step In Incision Management: Reducing Surgical Wound Dehiscence

Surgical wound dehiscence is one of the most dreaded & costly of surgical complications. It is distu...

Read More >

No Undermining? Are You Kidding Me?

By: Dan Ladizinsky, MD, CEO, SUTUREGARD Medical, Retired Board Certification in General Surgery, Pla...

Read More >

Press Release - SUTUREGARD® Medical, Inc is Presenting at Arab Health

SUTUREGARD® Medical, Inc is excited to announce that CEO Dan Ladizinsky, MD, will be presenting SUTU...

Read More >

How Will My Surgeon Repair My Wound?

A surgical wound can be managed in many ways. The choice of management varies depending on body loca...

Read More >

What is Squamous Cell Carcinoma (SCC)?

Squamous cell carcinoma (SCC) is the second most common skin cancer. While basal cell carcinoma (BCC...

Read More >

Prevent and Manage Wound Dehiscence.

Making wound closure easier for surgeons and better for patients.

Contact Us